What Is “The Matter” With Restenosis in 2002?-Reference-Cited by-同舟云学术

What Is “The Matter” With Restenosis in 2002?

Published:2002-06-25 Issue:25 Volume:105 Page:2932-2933
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Sousa J. Eduardo¹,Costa Marco A.¹,Sousa Amanda G.M.R.¹

Affiliation:

1. From the Institute Dante Pazzanese of Cardiology (J.E.S., A.G.M.R.S.), São Paulo, Brazil; and the University of Florida-Shands (M.A.C.), Jacksonville, Fla.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000023396.71735.65

Reference16 articles.

1. Morphological Predictors of Restenosis After Coronary Stenting in Humans

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Apoptotic Signaling and Neointimal Hyperplasia by Tempol and Nitric Oxide Synthase following Vascular Injury;Journal of Vascular Research;2009

2. Update on Drug-Eluting Stents for Prevention of Restenosis;Asian Cardiovascular and Thoracic Annals;2006-02

3. Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats;American Journal of Physiology-Heart and Circulatory Physiology;2005-09

4. Interfacial biology of in-stent restenosis;Expert Review of Medical Devices;2005-07

5. Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys;Gene Therapy;2004-06-03